MedTrace Logo

Modulating the Vaginal Microbiome After Implantation Failure

NCT03843112 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2021-03-23

No results posted yet for this study

Summary

Vaginal microbiome has in studies shown a link with the outcome of fertility treatment. The investigators wish to determine if it is possible to change an unfavorable vaginal microbiome using lactobacilli loaded vaginal supplements.

Conditions

  • Implantation Failure
  • Infertility, Female
  • Vaginal Flora Imbalance

Interventions

DRUG

Vivag Plus

Contains two lactobacilli strains; l. gasseri and l. rhamnosus

DRUG

Placebo - Cap

Vaginal supplements

Sponsors & Collaborators

  • ARTPred

    collaborator UNKNOWN

  • Bifodan A/S

    collaborator UNKNOWN

  • Zealand University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2021-01-05
Completion
2021-02-27

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03843112 on ClinicalTrials.gov